2,410.00p
+0.75%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Genus
Its shares trade on LSE under the ticker GNS.L. It has been listed since 6 July 2000. In the fiscal year to 30 June 2026, it reported revenue of £658.1m and net income of £285.3m. At that date it held total assets of £1.02bn and shareholders' equity of £766.7m.
Genus Plc engages in the provision of genetic livestock services to produce meat and milk. The company is headquartered in Basingstoke, Hampshire. The company went IPO on 2000-07-06. The firm's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment is engaged in bovine sales business, excluding Asia, and serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment is engaged in porcine and bovine business in Asia, and serves porcine, dairy and beef customers in Asian markets. In the porcine market, it sells boars and sows. In the dairy and beef markets, its primary product is bull semen. The firm offers embryos through its subsidiary, In Vitro Brasil S.A. Its porcine business has a network of over 600 breeding herds in approximately 40 countries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 6 Jul 2000
- Employees
- 2,969
- Website
- genusplc.com ↗
Leadership
Pay as last reported
- Mr. Iain FergusonNon-Executive Independent Chairman of the Board£230,000
- Mr. Jorgen KokkeChief Executive Officer, Executive Director, since 2023$1.8m
- Mr. Andy RussellChief Financial Officer, Executive Director, since 2025
- Dr. Matt CulbertsonChief Operating Officer
- Ms. Angelle RosataChief Human Resources Officer
- Dr. Elena RiceChief Scientific Officer and Head of Research and Development
- Mr. Dan HartleyGroup General Counsel and Company Secretary
- Mr. Jim LowChief Operating Officer of Genus ABS
- Mr. Jerry ThompsonRegional Director - ABS EMEA
- Ms. Lysanne GrayNon-Executive Independent Director£68,000
- Dr. Ralph HeuserNon-Executive Independent Director£28,000
- Ms. Lesley KnoxSenior Non-Executive Independent Director£65,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 72
- Environment
- 67
- Social
- 88
- Governance
- 63
- Direct emissions (scope 1)
- 66,977 t
- Energy emissions (scope 2)
- 11,991 t
- Value chain emissions (scope 3)
- 465,803 t
- Women in the workforce
- 35.1%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Genus PLC possesses several strengths that contribute to its competitive advantage. These strengths include:
Weaknesses
- While Genus PLC has many strengths, there are also some weaknesses that may hinder its performance. These weaknesses include:
Opportunities
- Genus PLC can capitalize on various opportunities to further expand and enhance its business. These opportunities include:
Threats
- However, Genus PLC also faces certain threats that could impact its operations and profitability. These threats include:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.